pramipexole has been researched along with Sensitivity and Specificity in 12 studies
*Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gmeiner, P; Hübner, H; Löber, S | 1 |
| Chen, J; Collins, GT; Levant, B; Wang, S; Woods, J; Yang, CY; Zhang, J | 1 |
| Ghasemi, E; Ghorban Dadrass, O; Kheradmand, S | 1 |
| He, P; Kerr, D; Stecher, S; Wei, D; Wu, C; Yang, L | 1 |
| Kenndler, E; Morganti, E; Musenga, A; Raggi, MA; Rasi, F | 1 |
| Bharathi, DV; Hotha, KK; Kumar, SS; Mullangi, R; Naidu, A; Sagar, PV | 1 |
| Menon, SK; Panchal, JG; Patel, RV | 1 |
| Morrish, PK | 1 |
| Ajjala, D; Kandikere, V; Maurya, S; Mudigonda, K; Nirogi, RV; Shrivastava, W | 1 |
| Hanson, GD; Ichhpurani, N; Lau, YY; Selenka, JM; Talaat, R | 1 |
| Hanson, GD; Ichhpurani, N; Lau, YY | 1 |
| Bala, MV; Chrischilles, EA; Greer, M; Hoerger, TJ; Holloway, RG; Rowland, C | 1 |
1 trial(s) available for pramipexole and Sensitivity and Specificity
| Article | Year |
|---|---|
Chiral liquid chromatography-tandem mass spectrometry assay to determine that dexpramipexole is not converted to pramipexole in vivo after administered in humans.
Topics: Amyotrophic Lateral Sclerosis; Benzothiazoles; Chromatography, Liquid; Drug Stability; Humans; Placebos; Pramipexole; Quality Control; Sensitivity and Specificity; Stereoisomerism; Tandem Mass Spectrometry | 2014 |
11 other study(ies) available for pramipexole and Sensitivity and Specificity
| Article | Year |
|---|---|
Fused azaindole derivatives: molecular design, synthesis and in vitro pharmacology leading to the preferential dopamine D3 receptor agonist FAUC 725.
Topics: Aza Compounds; Dopamine Agonists; Drug Design; Heterocyclic Compounds, 3-Ring; Humans; Indoles; Models, Molecular; Protein Binding; Receptors, Dopamine D2; Receptors, Dopamine D3; Sensitivity and Specificity; Static Electricity; Structure-Activity Relationship | 2002 |
Design, synthesis, and evaluation of potent and selective ligands for the dopamine 3 (D3) receptor with a novel in vivo behavioral profile.
Topics: Animals; Behavior, Animal; Benzothiazoles; Binding Sites; Binding, Competitive; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Design; Humans; Hydrogen Bonding; Hypothermia; Ligands; Models, Molecular; Molecular Conformation; Pramipexole; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Sensitivity and Specificity; Solubility; Stereoisomerism; Structure-Activity Relationship; Yawning | 2008 |
Solvent bar microextraction combined with high-performance liquid chromatography for preconcentration and determination of pramipexole in biological samples.
Topics: Benzothiazoles; Chemical Fractionation; Chromatography, High Pressure Liquid; Humans; Linear Models; Pramipexole; Reproducibility of Results; Sensitivity and Specificity | 2014 |
Analysis of the anti-Parkinson drug pramipexole in human urine by capillary electrophoresis with laser-induced fluorescence detection.
Topics: Analytic Sample Preparation Methods; Antiparkinson Agents; Benzothiazoles; Electrophoresis, Capillary; Fluorescence; Health; Humans; Lasers; Pramipexole; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Development and validation of a sensitive LC-MS/MS method with electrospray ionization for quantitation of pramipexole in human plasma: application to a clinical pharmacokinetic study.
Topics: Benzothiazoles; Chromatography, Liquid; Dopamine Agonists; Drug Stability; Humans; Linear Models; Memantine; Pramipexole; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2009 |
Development and validation of GC/MS method for determination of pramipexole in rat plasma.
Topics: Animals; Benzothiazoles; Caffeine; Dopamine Agonists; Drug Stability; Gas Chromatography-Mass Spectrometry; Linear Models; Pramipexole; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity | 2011 |
REAL and CALM: what have we learned?
Topics: Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Corpus Striatum; Disease Progression; Dopamine; Feasibility Studies; Humans; Indoles; Levodopa; Neurons; Neuroprotective Agents; Parkinson Disease; Pramipexole; Putamen; Reference Values; Sensitivity and Specificity; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
Quantification of pramipexole in human plasma by liquid chromatography tandem mass spectrometry using tamsulosin as internal standard.
Topics: Administration, Oral; Benzothiazoles; Biological Availability; Calibration; Chromatography, High Pressure Liquid; Drug Stability; Humans; Molecular Structure; Pramipexole; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Specimen Handling; Spectrometry, Mass, Electrospray Ionization; Sulfonamides; Tamsulosin; Tandem Mass Spectrometry | 2007 |
Determination of pramipexole (U-98,528) in human plasma by high-performance liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry.
Topics: Administration, Oral; Atmospheric Pressure; Azepines; Benzothiazoles; Calibration; Chromatography, High Pressure Liquid; Dopamine Agonists; Humans; Linear Models; Mass Spectrometry; Pramipexole; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Thiazoles | 1996 |
Determination of pramipexole (U-98,528) in human plasma and urine by high-performance liquid chromatography with electrochemical and ultraviolet detection.
Topics: Azepines; Benzothiazoles; Calibration; Chromatography, High Pressure Liquid; Dopamine Agonists; Drug Stability; Electrochemistry; Humans; Linear Models; Osmolar Concentration; Pramipexole; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Thiazoles; Time Factors | 1996 |
Cost effectiveness of pramipexole in Parkinson's disease in the US.
Topics: Antiparkinson Agents; Benzothiazoles; Cost-Benefit Analysis; Humans; Parkinson Disease; Pramipexole; Quality-Adjusted Life Years; Sensitivity and Specificity; Thiazoles; United States | 1998 |